Mapping Pathways to HIV Prevention
Molly Morgan Jones, a Research Leader in RAND Europe, discusses how antiretroviral (ARV)-based HIV prevention strategies need to be closely tailored to local contexts and cultures in order to make an impact on new HIV infections globally.
Mapping Pathways: Developing evidence-based, people-centred strategies for the use of antiretrovirals as prevention
This is the first international report on HIV prevention with antiretroviral (ARV) drugs that brings scientific evidence together with community perspectives. We show that ARV-based prevention needs to be tailored to local contexts and cultures.